Curia Global, Inc. (Curia), a leading contract research, development and manufacturing organization, today announced ...

BioPlan Associates presents research and projections on the pharma sterile fill-finish industry’s future over the next 10 ...

Curia Global Inc (Curia), a contract research, development and manufacturing organisation (CDMO), has announced the expansion ...

Curia will expand its Glasgow, UK facility and offers updates on the ongoing expansion to its Albuquerque, NM facility.

Curia’s sterile fill-finish facility in Glasgow will add an integrated, isolator-based vial filling line and lyophilizer suitable for a broad range of drug product including highly potent ...

Curia's sterile fill-finish facility in Glasgow will add an integrated, isolator-based vial filling line and lyophilizer suitable for a broad range of drug product including highly potent capabilities ...

ALBANY, N.Y., March 17, 2025 (GLOBE NEWSWIRE) — Curia Global, Inc. (Curia), a leading contract research, development and manufacturing organization, today announced expansion plans to its ...

The expansion addresses US injectable capacity shortages and growing demand for reliable domestic sterile manufacturing.

The Noramco Group has announced a $25 million investment to expand its Halo Pharma facility in Whippany, New Jersey, by ...